These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 25252395)

  • 1. Using molecular profiling diagnostics to identify predictive biomarkers in metastatic cancer.
    Van Tine BA
    MLO Med Lab Obs; 2014 Sep; 46(9):18, 20-1. PubMed ID: 25252395
    [No Abstract]   [Full Text] [Related]  

  • 2. Sequencing efforts help to refine the molecular classification of breast cancer.
    Konecny GE
    Curr Opin Obstet Gynecol; 2014 Feb; 26(1):18-20. PubMed ID: 24346129
    [No Abstract]   [Full Text] [Related]  

  • 3. Markers for the prediction of metastatic potential in breast cancer.
    Mitchell B
    Br J Biomed Sci; 1996 Dec; 53(4):327-8. PubMed ID: 9069113
    [No Abstract]   [Full Text] [Related]  

  • 4. Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patients.
    Welt A; Tewes M; Aktas B; O Hoffmann O; Wiesweg M; Ting S; Reis H; Worm K; Richly H; Hense J; Palmer MR; Lee BH; Wendling J; Kossow J; Scheulen ME; Lehnerdt C; Kohl M; Derks C; Skottky S; Haus U; Schmid KW; Kimmig R; Schuler M; Kasper S
    Breast Cancer Res Treat; 2013 Nov; 142(1):81-8. PubMed ID: 24122392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Response predictive biomarkers to targeted therapies in oncology].
    Harlé A; Merlin JL
    Ann Biol Clin (Paris); 2013 Nov; 71():89-97. PubMed ID: 24235332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new path to the cancer epigenome.
    Richon VM
    Nat Biotechnol; 2008 Jun; 26(6):655-6. PubMed ID: 18536689
    [No Abstract]   [Full Text] [Related]  

  • 8. Identifying Reproducible Molecular Biomarkers for Gastric Cancer Metastasis with the Aid of Recurrence Information.
    Li M; Hong G; Cheng J; Li J; Cai H; Li X; Guan Q; Tong M; Li H; Guo Z
    Sci Rep; 2016 Apr; 6():24869. PubMed ID: 27109211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In practice for the pathologist: practical and technical limitations].
    Rochaix P
    Ann Pathol; 2011 Nov; 31(5 Suppl):S43-5. PubMed ID: 22054457
    [No Abstract]   [Full Text] [Related]  

  • 10. [Molecular diagnostics in oncology].
    Imianitov EN
    Vopr Onkol; 2012; 58(2):153-63. PubMed ID: 22774518
    [No Abstract]   [Full Text] [Related]  

  • 11. [Molecular diagnostics in pathology].
    Stenzinger A; Penzel R; Endris V; Weichert W
    Dtsch Med Wochenschr; 2013 May; 138(20):1061-8. PubMed ID: 23670263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel biomarkers of metastatic cancer.
    Dawood S
    Expert Rev Mol Diagn; 2010 Jul; 10(5):581-90. PubMed ID: 20629508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of immunohistochemistry in detecting the primary site in neoplasm metastasis].
    de Almeida PC; Pestana CB
    AMB Rev Assoc Med Bras; 1989; 35(3):84-7. PubMed ID: 2699378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration of serum HER-2/neu as a prognostic factor in locally advanced breast cancer (LABC) and metastatic breast cancer (MBC).
    Purwanto I; Kurnianda J; Hariadi KW; Harijadi ; Aryandono T; Setiaji K; Harianti MS; Haryana SM
    Acta Med Indones; 2011 Jan; 43(1):23-8. PubMed ID: 21339542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of sentinel lymph nodes and search for molecular signatures of the metastatic potential of breast cancer.
    Hoon DS; Bernet L; Cano R; Viale G
    Q J Nucl Med Mol Imaging; 2014 Jun; 58(2):180-92. PubMed ID: 24835292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype.
    Chekhun S; Bezdenezhnykh N; Shvets J; Lukianova N
    Exp Oncol; 2013 Sep; 35(3):174-9. PubMed ID: 24084454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular prediction of recurrence of breast cancer.
    Lombardo JF
    N Engl J Med; 2005 Sep; 353(12):1300; author reply 1300. PubMed ID: 16177260
    [No Abstract]   [Full Text] [Related]  

  • 18. [Early breast carcinoma profiling based on quantitative immunocytochemistry can help predict the risk of early distant metastasis].
    Taranger-Charpin C; Giusiano S; Secq V; Djemli A; Andrac L; Lavaut MN; Allasia C; Garcia S
    Bull Acad Natl Med; 2009 Dec; 193(9):2045-60; discussion 2060-1. PubMed ID: 20666017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis.
    Han HJ; Russo J; Kohwi Y; Kohwi-Shigematsu T
    Nature; 2008 Mar; 452(7184):187-93. PubMed ID: 18337816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early diagnosis of breast cancer dissemination by tumor markers follow-up and method of prediction.
    Nekulová M; Simícková M; Pecen L; Eben K; Vermousek I; Stratil P; Cernoch M; Lang B
    Neoplasma; 1994; 41(2):113-8. PubMed ID: 8208314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.